- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04827316
Clinical Utility and Outcome Prediction of Cardiovascular Computed Tomography (PREDICT-CT) (PREDICT-CT)
In this study the investigators retrospectively and prospectively collect information from enrolled subjects undergoing CCTA and evaluate the association of cardiac and non-cardiac imaging with laboratory markers and clinical data including outcome.
Study Overview
Status
Detailed Description
In this study the investigators retrospectively and prospectively collect information from enrolled subjects through a period of a total of 10 years to evaluate multidimensional associations between phenotypic manifestations of cardiovascular disease via CCTA and cardiac and non-cardiac imaging, serum biomarkers, demographic and clinical information, clinical presentation (cross-sectional), therapy changes (time-varying) and their ability to predict mortality and MACE (major adverse cardiac event ) (longitudinal) in patients clinically indicated for CCTA.
The aim is to establish a comprehensive cross-sectional, time-varying and longitudinal data collection for individuals undergoing clinically-indicated CCTA to date in order to apply novel multiparametric approaches to determine cardiovascular significance to clinically-important patient-centered events. For data collection this registry will follow a standard CRF (case report form) structure, so to enable the merging of this data-set with other international registries, which might contribute in overcoming some gaps of knowledge from previous CCTA studies.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Christoph Gräni, MD, PHD
- Phone Number: +41 31 632 4508
- Email: christoph.graeni@insel.ch
Study Locations
-
-
-
Bern, Switzerland, 3010
- Recruiting
- Department of Cardiology, University Hospital Bern, Inselspital, Bern
-
Contact:
- Christoph Gräni, Prof
- Phone Number: +41316324508
- Email: christoph.graeni@insel.ch
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
The registry foreseen a prospective cohort composed by patients undergoing clinically indicated CCTA and by a retrospective population of patients that have undergone CCTA 1st June 2017 to 31st December 2020. The principal investigator confirms that no patient's personal health data will be collected if a written or documented oral refusal exist.
Description
Inclusion Criteria:
- Adult individual >18 years
- Undergoing clinically indicated CCTA
- Signed informed consent or waiver
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: PROSPECTIVE
Cohorts and Interventions
Group / Cohort |
|---|
|
Patients undergoing clinically indicated CCTA
Patients undergoing clinically indicated CCTA |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
All-cause death.
Time Frame: 10 years
|
The primary endpoint is the time to first occurrence of death from all-causes. |
10 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Major adverse cardiovascular events (MACE)
Time Frame: 10 years
|
The secondary composite endpoint is major adverse cardiac events (MACE), which is defined by the occurrence of any of the following events:
|
10 years
|
|
Other outcome
Time Frame: 10 years
|
Occurrence of any of the following events:
|
10 years
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Christoph Gräni, MD, PhD, Department of Cardiology, University Hospital Bern,
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-00058
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.